Beta Drugs Ltd.

NSE: BETA | BSE: 531481 | ISIN: INE351Y01019 | Industry: Pharmaceuticals
|
1549.4000 -51.80 (-3.24%)
NSE Dec 18, 2025 15:31 PM
Volume: 4,303
 

logo
Beta Drugs Ltd.
03 Sep 2023
1549.40
-3.24%
buy
by Edelweiss
Target: 1325
Edelweiss
Beta Drugs (BETADR) is one of the leading players in the domestic oncology space and ranks among the top 10 in the cytotoxic market.
 
Beta Drugs Ltd. is trading below all available SMAs
More from Beta Drugs Ltd.
Recommended
Market closes flat as gains in financials & IT stocks offset losses in other sectors
Trendlyne Marketwatch | 18 Dec 2025, 04:19PM
Global aviation is growing, but competition is not
The Baseline | 18 Dec 2025, 01:35PM
Are Indian consumers running out of choices?
The Baseline | 17 Dec 2025, 06:13PM